Recurrent thrombosis in a multiple myeloma patient with low risk for thrombosis despite being on thromboprophylaxis
Open Access
- 19 February 2019
- journal article
- Published by Peertechz Publications Private Limited in Archives of Hematology Case Reports and Reviews
- Vol. 4 (1), 003-005
- https://doi.org/10.17352/ahcrr.000015
Abstract
It is a well-known fact that multiple myeloma (MM) patients have an increased risk for thromboembolic events involving both the venous and arterial territories.Keywords
This publication has 15 references indexed in Scilit:
- Update of thrombosis in multiple myelomaThrombosis Research, 2016
- Thrombosis is associated with inferior survival in multiple myelomaHaematologica, 2012
- Thrombosis in multiple myeloma (MM)Hematology, 2012
- Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomideBlood, 2012
- Low Venous Thromboembolic Risk With Bortezomib in Multiple Myeloma and Potential Protective Effect With Thalidomide/Lenalidomide-based Therapy: Review of Data From Phase 3 Trials and Studies of Novel Combination RegimensClinical Lymphoma Myeloma and Leukemia, 2011
- Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: a systematic review and meta‐analysisJournal of Thrombosis and Haemostasis, 2011
- High incidence of arterial thrombosis in young patients treated for multiple myeloma: results of a prospective cohort studyBlood, 2010
- Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based studyBlood, 2010
- Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myelomaBlood, 2008
- Lenalidomide and Venous Thrombosis in Multiple MyelomaThe New England Journal of Medicine, 2006